HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Riichiro Abe Selected Research

mouse LPAR6 protein

5/2010Prevalent LIPH founder mutations lead to loss of P2Y5 activation ability of PA-PLA1alpha in autosomal recessive hypotrichosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Riichiro Abe Research Topics

Disease

13Neoplasms (Cancer)
04/2022 - 02/2004
13Stevens-Johnson Syndrome (Lyell's Syndrome)
12/2020 - 05/2003
6Inflammation (Inflammations)
01/2019 - 04/2004
5Mycosis Fungoides
02/2022 - 05/2006
5Hypersensitivity (Allergy)
01/2022 - 08/2015
5Drug-Related Side Effects and Adverse Reactions
01/2022 - 07/2011
5Melanoma (Melanoma, Malignant)
01/2008 - 02/2004
4Eosinophilia
01/2022 - 03/2015
4Skin Manifestations
09/2021 - 07/2009
4Hemangiosarcoma (Angiosarcoma)
10/2020 - 05/2013
4Atopic Dermatitis (Atopic Eczema)
09/2020 - 07/2006
4Bullous Pemphigoid (Pemphigoid)
02/2020 - 01/2008
4Diabetic Retinopathy (Retinopathy, Diabetic)
01/2008 - 12/2002
3Psoriasis (Pustulosis Palmaris et Plantaris)
03/2021 - 09/2002
3Epidermolysis Bullosa
04/2017 - 08/2010
3Wounds and Injuries (Trauma)
02/2008 - 12/2005
2Drug Hypersensitivity Syndrome
01/2022 - 03/2015
2Exanthema (Rash)
01/2019 - 01/2018
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2017 - 01/2003
2Pemphigus (Pemphigus Vulgaris)
01/2017 - 03/2012
2Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis)
09/2009 - 01/2009
2Eye Diseases (Eye Disease)
01/2008 - 04/2004
2Neoplasm Metastasis (Metastasis)
06/2007 - 02/2004
1Neutropenia
02/2022
1Hypertriglyceridemia
02/2022
1Hypercholesterolemia
02/2022
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
02/2022
1Chondrodysplasia Punctata (Stippled Epiphyses)
09/2021
1Diverticulitis
03/2021
1Embolism (Embolus)
01/2021
1Disease Progression
12/2020
1Rheumatoid Arthritis
10/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2020
1Pruritus (Itching)
09/2020
1Carcinogenesis
08/2020
1Hereditary Sensory and Autonomic Neuropathies (HSAN)
01/2020
1Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
01/2020
1Dystonia (Limb Dystonia)
01/2020

Drug/Important Bio-Agent (IBA)

14Pharmaceutical PreparationsIBA
01/2022 - 05/2003
9Proteins (Proteins, Gene)FDA Link
12/2020 - 12/2002
9Macrophage Migration-Inhibitory FactorsIBA
04/2011 - 03/2002
6Fas Ligand Protein (Fas Ligand)IBA
12/2008 - 01/2003
5Collagen Type XVIIIBA
04/2017 - 01/2009
5pigment epithelium-derived factorIBA
03/2010 - 04/2004
3Biomarkers (Surrogate Marker)IBA
09/2020 - 08/2018
3Immunoglobulins (Immunoglobulin)IBA
07/2020 - 08/2015
3EnzymesIBA
01/2018 - 05/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2013 - 04/2004
2AntibodiesIBA
10/2020 - 04/2017
2LigandsIBA
09/2020 - 12/2006
2Immunoglobulin E (IgE)IBA
09/2020 - 07/2009
2Infliximab (Remicade)FDA Link
10/2018 - 02/2018
2AntigensIBA
01/2018 - 04/2017
2Peptides (Polypeptides)IBA
01/2018 - 03/2010
2Immunoglobulin G (IgG)IBA
04/2017 - 01/2017
2Immunoglobulin A (IgA)IBA
04/2017 - 03/2012
2ChemokinesIBA
04/2017 - 12/2006
2CytokinesIBA
04/2011 - 07/2006
2DNA (Deoxyribonucleic Acid)IBA
07/2009 - 12/2004
2Advanced Glycation End ProductsIBA
01/2008 - 02/2004
2Receptor for Advanced Glycation End ProductsIBA
06/2007 - 02/2004
2Neutralizing AntibodiesIBA
12/2006 - 02/2004
2glycolaldehydeIBA
02/2004 - 12/2002
2GlyceraldehydeIBA
02/2004 - 12/2002
1Mucin-1 (CA 15-3 Antigen)IBA
04/2022
1S100 Proteins (S 100 Protein)IBA
04/2022
1Bexarotene (LGD1069)FDA Link
02/2022
1Carrier Proteins (Binding Protein)IBA
09/2021
1emopamil (levemopamil)IBA
09/2021
1risankizumabIBA
03/2021
1PolymersIBA
01/2021
1MicroRNAs (MicroRNA)IBA
12/2020
1taxaneIBA
10/2020
1Caspase 3 (Caspase-3)IBA
10/2020
1Rheumatoid FactorIBA
10/2020
1SurvivinIBA
10/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
10/2020
1Anti-Citrullinated Protein AntibodiesIBA
10/2020
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2020
1EndoglinIBA
10/2020
1cadherin 5IBA
10/2020
1PaxillinIBA
10/2020
1Interleukin-22 (IL-22)IBA
09/2020
1PeriostinIBA
09/2020
1Interleukin-33IBA
09/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2020
1Thymic Stromal LymphopoietinIBA
09/2020
1dupilumabIBA
09/2020
1Interleukin-2 Receptors (IL 2 Receptor)IBA
09/2020
1Interleukin-13IBA
09/2020
1CC ChemokinesIBA
09/2020
1Dynamins (Dynamin)IBA
08/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2020
1Phenytoin (Dilantin)FDA LinkGeneric
01/2020

Therapy/Procedure

13Therapeutics
02/2022 - 02/2004
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2015 - 08/2010
3Drug Therapy (Chemotherapy)
05/2013 - 06/2007
2Hematopoietic Stem Cell Transplantation
03/2016 - 06/2009
2Intradermal Injections
02/2008 - 12/2006
1Endovascular Procedures
01/2021